We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 2,442 results
  1. Regulatory Considerations Toward Orphan Drug Designation and Orphan Drug Exclusivity in the United States and European Union: Structural Similarity, Clinical Superiority/Significant Benefit, and Case Studies

    The U.S. Food and Drug Administration and European Commission have developed successful orphan drug legislation to promote the research, development,...

    Scott W. Roberts, Tara Laura Brandt Elvang, ... Tue Anker Mikkelsen in Therapeutic Innovation & Regulatory Science
    Article 18 November 2022
  2. Hierarchical Assessment of the Structural Similarity of Pharmacologically Active Compounds

    Anew method for assessing the structural similarity of pharmacologically active substances based on a hierarchical description of the chemical...

    P. M. Vasil’ev, A. N. Kochetkov, ... O. A. Popov in Pharmaceutical Chemistry Journal
    Article 11 January 2021
  3. Linguistic Analysis of Generic-Generic Drug Name Pairs Prone to Wrong-Drug Errors for which Tall-Man Lettering is Recommended

    Objective

    The Institute for Safe Medication Practices (ISMP) and the United States Food and Drug Administration (FDA) disseminated widely used lists...

    Article Open access 12 May 2023
  4. Development of a Method for Assay of Flavonoids and Chlorhexidine in Medicinal Wound-Healing Pencil Formulations

    Amethod for selective assay of flavonoids and chlorhexidine bigluconate in medicinal wound-healing pencils was developed using differential...

    E. B. Nikiforova, N. A. Davitavyan, ... A. G. Nechaeva in Pharmaceutical Chemistry Journal
    Article 31 March 2022
  5. Chemodiversity and Trypanocidal Activity of the Volatile Oils of Tropical Black Sage

    Tropical black sage ( Varronia curassavica Jacq., Cordiaceae) is a species native to ecosystems subject to strong anthropic action, and thus is at...

    Elisabeth Alves Duarte Pereira de Medeiros, Rayssa Vicente Nascimento, ... Marco Andre Alves de Souza in Revista Brasileira de Farmacognosia
    Article 11 June 2024
  6. Identification of Confusing Medicine Proprietary Names: Toward Safe Medicine Use—A Cross-Sectional Study in Sri Lanka

    Background

    Look-alike sound-alike (LASA) medications have similar pronunciation (phonetic) and/or manifestation (orthographic), which could create...

    Manori Jayasinghe, Thotawaththage Loshadhi Indunika Srilal, ... Shukry Zawahir in Therapeutic Innovation & Regulatory Science
    Article 17 August 2023
  7. Assessing the severity of medication administration errors identified in an observational study using a valid and reliable method

    Background

    Epidemiological data on medication errors severity are scarce. The assessment of the prevalence and severity of medication errors may be...

    Lindemberg Assunção-Costa, Charleston Ribeiro Pinto, ... Luis Eugenio Portela Fernandes de Souza in Journal of Pharmaceutical Policy and Practice
    Article Open access 14 November 2023
  8. Are there sex differences in oxytocin and vasopressin V1a receptors ligand binding affinities?

    Background

    There is substantial evidence for sex differences in the functioning of one of the most common receptor systems; G protein-coupled...

    Jack H. Taylor, H. Elliott Albers in Pharmacological Reports
    Article 13 March 2024
  9. Strength-Dependent and Strength-Independent Dissolution Patterns of Poorly-Soluble Drugs. Case Example: Valsartan

    This study aims to investigate the strength-dependent dissolution pattern of two-dose strengths of valsartan: the low-dose strength of 80 mg and...

    Rania Hamed, Areej Kamal in Pharmaceutical Chemistry Journal
    Article 06 March 2021
  10. Evaluation of Quality Control Parameters of Expired and Non-Expired Tablets Containing Poorly Water-Soluble Drug (Clopidogrel) with Emphasis on Dissolution Stability

    Clopidogrel is an antiplatelet drug available as tablet dosage form (75 mg) alone and in combination with other drugs like aspirin. It is a BCS class...

    Maria Kakar, Amjad Khan in Pharmaceutical Chemistry Journal
    Article 17 August 2022
  11. Isoflavone-Rich Extract of Trifolium resupinatum: Anti-obesity Attributes with In Silico Investigation of Its Constituents

    Trifolium resupinatum L., Fabaceae, aqueous methanol leaf extract was selected to mitigate some obesity-associated risk factors to validate the...

    Mona M. Marzouk, Alia Y. Ragheb, ... Mona E. S. Kassem in Revista Brasileira de Farmacognosia
    Article Open access 02 January 2024
  12. Oritavancin (KIMYRSA™) in acute bacterial skin and skin structure infections: a profile of its use in the USA

    Oritavancin, a long-acting lipoglycopeptide, is the first single-dose intravenous (IV) antibacterial therapy approved in the USA for the treatment of...

    Article Open access 05 February 2022
  13. The essential role of TAZ in normal tissue homeostasis

    Transcriptional coactivator with PDZ-binding motif (TAZ) has been extensively characterized in organ development, tissue regeneration, and tumor...

    Mi Gyeong Jeong, Hyo Kyeong Kim, Eun Sook Hwang in Archives of Pharmacal Research
    Article Open access 26 March 2021
  14. Cutting Through the “Gray Area”: An Analysis of the IBC Regulatory Oversight of Applications of CRISPR Technology in Clinical Research

    The advent of clustered regularly interspaced short palindromic repeats (CRISPR) technology has quickly ushered in a new era of gene editing and...

    Article 18 May 2021
  15. Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians

    Background

    With the approval of biosimilars for subcutaneously administered products, such as adalimumab, etanercept and insulin, biosimilars become...

    Liese Barbier, Yannick Vandenplas, ... Isabelle Huys in Journal of Pharmaceutical Policy and Practice
    Article Open access 22 June 2021
  16. Advancing medical affair capabilities and insight generation through machine learning techniques

    Background

    Pharmaceutical companies are increasingly leveraging machine learning techniques to optimize healthcare research, drug development, and...

    Karen Ka Yan Ng, Peter Chengming Zhang in Journal of Pharmaceutical Policy and Practice
    Article Open access 01 December 2023
  17. Expert Commentary: Diverse Meanings of Regulatory “Convergence”

    The term regulatory “convergence” is apparently given many meanings in the field of medical products. Originally defined as a process of making...

    Article 03 March 2020
  18. Bayesian Design for Pediatric Clinical Trials with Binary Endpoints When Borrowing Historical Information of Treatment Effect

    The efficacy evaluation in pediatric population is an important component of drug development and is generally required by the regulatory agencies....

    Man **, Qing Li, Amarjot Kaur in Therapeutic Innovation & Regulatory Science
    Article 21 September 2020
  19. Weighted gene co-expression network analysis for hub genes in colorectal cancer

    Background

    This study is designed to explore hub genes participating in colorectal cancer (CRC) development through weighted gene co-expression...

    Zheng Xu, Jianing Wang, Guosheng Wang in Pharmacological Reports
    Article 27 December 2023
Did you find what you were looking for? Share feedback.